KeyBank National Association’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-9,220
| Closed | -$657K | – | 1006 |
|
|
2019
Q2 | $657K | Buy |
9,220
+6,553
| +246% | +$467K | ﹤0.01% | 670 |
|
|
2019
Q1 | $209K | Sell |
2,667
-1,403
| -34% | -$110K | ﹤0.01% | 899 |
|
|
2018
Q4 | $345K | Buy |
4,070
+114
| +3% | +$9.66K | ﹤0.01% | 752 |
|
|
2018
Q3 | $677K | Sell |
3,956
-212
| -5% | -$36.3K | ﹤0.01% | 683 |
|
|
2018
Q2 | $539K | Sell |
4,168
-8
| -0.2% | -$1.04K | ﹤0.01% | 720 |
|
|
2018
Q1 | $430K | Buy |
4,176
+98
| +2% | +$10.1K | ﹤0.01% | 786 |
|
|
2017
Q4 | $348K | Buy |
4,078
+205
| +5% | +$17.5K | ﹤0.01% | 848 |
|
|
2017
Q3 | $329K | Buy |
3,873
+923
| +31% | +$78.4K | ﹤0.01% | 895 |
|
|
2017
Q2 | $223K | Sell |
2,950
-684
| -19% | -$51.7K | ﹤0.01% | 1026 |
|
|
2017
Q1 | $240K | Buy |
+3,634
| New | +$240K | ﹤0.01% | 1037 |
|